Skip to main content
Premium Trial:

Request an Annual Quote



Nascent drug maker Cytochroma, of Markham, Ontario, which focuses on identifying small molecules that target cytochrome P450 gene mutations, said it has uncovered a gene that metabolizes 9-cis retinoic acid.

The gene, CYP26C, is generally understood to be the third member of the CYP450 gene family, which metabolize all-trans retinoic acid. The other two genes, CYP26A and CYP26B, do not do this.

So far, Cytochroma CSO Martin Petkovich has published a study showing that CYP26A is expressed in murine embryonic hindbrain, inner ear, and tooth buds.

The company said it is currently looking for partners to develop the discovery.

Filed under

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.